Get started
ZEALAND PHARMA A/SZEALAND PHARMA A/SZEALAND PHARMA A/S

ZEALAND PHARMA A/S

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ZEAL chart


Full chart

ZEAL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪51.45 B‬ DKK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−16.5 DKK
Net income (FY)
‪−703.74 M‬ DKK
Revenue (FY)
‪342.79 M‬ DKK
Shares float
‪63.31 M‬
Beta (1Y)
0.86

Employees


Employees (FY)
253
Change (1Y)
+57 +29.08%
Revenue / Employee (1Y)
‪1.35 M‬ DKK
Net income / Employee (1Y)
‪−2.78 M‬ DKK

About ZEALAND PHARMA A/S


Sector
Health Technology
CEO
Adam Sinding Steensberg
Headquarters
Soborg
Website
zealandpharma.com
Founded
1997
ISIN
DK0060257814
FIGI
BBG0018JWYS7
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ZEAL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ZEAL is 728.0 DKK — it has decreased by −3.77% in the past 24 hours. Watch ZEALAND PHARMA A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange ZEALAND PHARMA A/S stocks are traded under the ticker ZEAL.
ZEAL stock has fallen by −9.28% compared to the previous week, the month change is a 4.82% rise, over the last year ZEALAND PHARMA A/S has showed a 96.97% increase.
We've gathered analysts' opinions on ZEALAND PHARMA A/S future price: according to them, ZEAL price has a max estimate of 1,100.00 DKK and a min estimate of 750.00 DKK. Watch ZEAL chart and read a more detailed ZEALAND PHARMA A/S stock forecast: see what analysts think of ZEALAND PHARMA A/S and suggest that you do with its stocks.
ZEAL reached its all-time high on Jul 10, 2024 with the price of 972.0 DKK, and its all-time low was 37.5 DKK and was reached on Nov 22, 2011. View more price dynamics on ZEAL chart.
See other stocks reaching their highest and lowest prices.
ZEAL stock is 28.88% volatile and has beta coefficient of 0.86. Track ZEALAND PHARMA A/S stock price on the chart and check out the list of the most volatile stocks — is ZEALAND PHARMA A/S there?
Today ZEALAND PHARMA A/S has the market capitalization of ‪51.43 B‬, it has increased by 5.94% over the last week.
Yes, you can track ZEALAND PHARMA A/S financials in yearly and quarterly reports right on TradingView.
ZEALAND PHARMA A/S is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ZEAL earnings for the last quarter are −3.75 DKK per share, whereas the estimation was −3.56 DKK resulting in a −5.33% surprise. The estimated earnings for the next quarter are −4.28 DKK per share. See more details about ZEALAND PHARMA A/S earnings.
ZEALAND PHARMA A/S revenue for the last quarter amounts to ‪4.42 M‬ DKK, despite the estimated figure of ‪66.66 M‬ DKK. In the next quarter, revenue is expected to reach ‪56.31 M‬ DKK.
ZEAL net income for the last quarter is ‪−266.40 M‬ DKK, while the quarter before that showed ‪−292.75 M‬ DKK of net income which accounts for 9.00% change. Track more ZEALAND PHARMA A/S financial stats to get the full picture.
No, ZEAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 253.00 employees. See our rating of the largest employees — is ZEALAND PHARMA A/S on this list?
Like other stocks, ZEAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZEALAND PHARMA A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZEALAND PHARMA A/S technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZEALAND PHARMA A/S stock shows the buy signal. See more of ZEALAND PHARMA A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.